Stellar Biotechnologies Stock Price, News & Analysis (NASDAQ:SBOT)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range
$4.44
MA: $59,624.23
$298,098.00
52-Week Range N/A
Volume625,292 shs
Average Volume2.95 million shs
Market Capitalization$1,588.86 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Stellar Biotechnologies, Inc, a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SBOT
CUSIPN/A
Phone805-488-2800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$210,000.00
Book Value$2.12 per share

Profitability

Net Income$-5,030,000.00
Net Margins-1,782.64%

Miscellaneous

Employees25
Market Cap$1,588.86 billion
Next Earnings Date11/29/2019 (Estimated)
OptionableNot Optionable

Receive SBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for SBOT and its competitors with MarketBeat's FREE daily newsletter.


Stellar Biotechnologies (NASDAQ:SBOT) Frequently Asked Questions

What is Stellar Biotechnologies' stock symbol?

Stellar Biotechnologies trades on the NASDAQ under the ticker symbol "SBOT."

When did Stellar Biotechnologies' stock split? How did Stellar Biotechnologies' stock split work?

Stellar Biotechnologies's stock reverse split on the morning of Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 4th 2018. An investor that had 100 shares of Stellar Biotechnologies stock prior to the reverse split would have 14 shares after the split.

How were Stellar Biotechnologies' earnings last quarter?

Stellar Biotechnologies Inc (NASDAQ:SBOT) released its earnings results on Wednesday, May, 8th. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analyst estimates of $0.11 million. Stellar Biotechnologies had a negative return on equity of 51.12% and a negative net margin of 1,782.64%. View Stellar Biotechnologies' Earnings History.

When is Stellar Biotechnologies' next earnings date?

Stellar Biotechnologies is scheduled to release their next quarterly earnings announcement on Friday, November 29th 2019. View Earnings Estimates for Stellar Biotechnologies.

Has Stellar Biotechnologies been receiving favorable news coverage?

Headlines about SBOT stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Stellar Biotechnologies earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Stellar Biotechnologies.

Who are some of Stellar Biotechnologies' key competitors?

What other stocks do shareholders of Stellar Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include Nexgen Energy (NXE), Progenics Pharmaceuticals (PGNX), Anavex Life Sciences (AVXL), Eyepoint Pharmaceuticals (EYPT), Opko Health (OPK), Rigel Pharmaceuticals (RIGL), Verastem (VSTM), XOMA (XOMA), Statoil (STO) and TransEnterix (TRXC).

Who are Stellar Biotechnologies' key executives?

Stellar Biotechnologies' management team includes the folowing people:
  • Mr. Frank R. Oakes, Chairman, Pres & CEO (Age 69)
  • Ms. Kathi Niffenegger CPA, CFO & Corp. Sec. (Age 62)
  • Mr. Gary Koppenjan, Sr. Director of Investor Relations & Communications
  • Brando Lincicum, Exec. Director of Aquaculture and Facility Operations

How big of a company is Stellar Biotechnologies?

Stellar Biotechnologies has a market capitalization of $0.00 and generates $210,000.00 in revenue each year. The biotechnology company earns $-5,030,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis. Stellar Biotechnologies employs 25 workers across the globe.View Additional Information About Stellar Biotechnologies.

What is Stellar Biotechnologies' official website?

The official website for Stellar Biotechnologies is http://www.stellarbiotechnologies.com/.

How can I contact Stellar Biotechnologies?

Stellar Biotechnologies' mailing address is 332 EAST SCOTT STREET, PORT HUENEME CA, 93041. The biotechnology company can be reached via phone at 805-488-2800 or via email at [email protected]


MarketBeat Community Rating for Stellar Biotechnologies (NASDAQ SBOT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  203 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  409
MarketBeat's community ratings are surveys of what our community members think about Stellar Biotechnologies and other stocks. Vote "Outperform" if you believe SBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel